Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Cochlear Limited (ASX:COH): FY2026 Results Highlight Nexa Platform, Global Growth and Earnings Recovery Focus

Cochlear Limited (ASX:COH) develops implantable hearing solutions for people with severe to profound hearing loss. The company operates a global healthcare technologyBusinesssupported by cochlear implant systems, services and acoustic products. During FY2026, Cochlear continued progressing its Nucleus Nexa System while managing changing market conditions …

Aditi Sarkar | 30 September 2026

Audeara Limited (ASX:AUA): Hearing Technology Partnerships Support Commercial Expansion

Audeara Limited (ASX:AUA) is an Australian hearing technology company developing personalised audio products and hearing-health solutions. During 2026, the company continued building commercial relationships across Australia and international markets while progressing product distribution and technology licensing opportunities.

Aditi Sarkar | 30 September 2026

Telix Pharmaceuticals (ASX:TLX) Receives FDA Fast Track Status for BiPASS Program

Fast Track is designed to facilitate development and potentially expedite review for therapies or products addressing serious conditions and unmet medical needs. For BiPASS, the designation may support closer FDA interaction, but it is not an approval. Use of Illuccix and Gozellix in the …

Aditi Sarkar | 30 September 2026

Ocean Sciences (ASX:OSS) Extends Takalar Seaweed Innovation Site Lease by Three Years

The lease is between a private Indonesian landowner and PT BPH Global Indonesia, a subsidiary of Ocean Sciences. It covers two adjoining parcels at Laikang Village, Mangarabombang District, Takalar Regency, totalling about 33,719 square metres, or 3.4 hectares. The site lies roughly 40 to …

Aditi Sarkar | 30 September 2026

Vitrafy Life Sciences Limited (ASX:VFY) Partners With Versiti Blood Health to Advance Platelet Cryopreservation Technology

Vitrafy Life Sciences Limited (ASX:VFY) is developing cryopreservation technologies designed to support the collection, preservation, storage and delivery of biological materials. The company’s shares were trading at AUD 3.760, up AUD 0.330 or 9.62% during the session. Vitrafy has announced a partnership with Versiti …

Aditi Sarkar | 30 September 2026

BCAL Diagnostics (ASX:BDX) Validates BREASTESTplus 2 Ahead of Planned November Launch

BREASTESTplus 2 uses an enhanced lipid biomarker panel for detecting early-stage breast cancer, covering Stage 0, Stage 1 and Stage 2. BCAL reported sensitivity of 80.3% and specificity of 48.5%. Of the breast cancers detected in the validation study, 61.9% were Stage 0 or …

Aditi Sarkar | 30 September 2026

Alcidion (ASX:ALC) Expands NHS Patient Flow Contract Across Four Greater Manchester Hospitals

The rollout starts with an upgrade of the ExtraMed Flow system at Salford Royal Hospital before extending to Royal Oldham Hospital, Fairfield General Hospital and Rochdale Infirmary. Miya Flow is built on Alcidion’s Miya Precision platform, which centralises information into dashboards and supports interoperability, …

Aditi Sarkar | 30 September 2026

Compumedics (ASX:CMP) Returns to FY2026 Profit as Revenue Reaches AUD 60.3 Million

FY2026 revenue increased from AUD 50.8 million to AUD 60.3 million. EBITDA rose to AUD 5.4 million from AUD 3.1 million, while net profit after tax reached AUD 0.3 million compared with a AUD 1.3 million loss in FY2025. EBITDAMarginincreased to 9% from 6%, …

Aditi Sarkar | 30 September 2026

AnteoTech (ASX:ADO) Maps FY2027 Priorities After AUD 1.9 Million R&D Incentive

The cash payment relates to eligible Australian research and development activities across AnteoTech’s Advanced Battery Technologies and Life ScienceBusinessunits during FY2026. The payment was received after the balance date and is therefore separate from the AUD 11.2 million held in the bank at 30 …

Aditi Sarkar | 30 September 2026

Cleo Diagnostics Ltd (ASX:COV) Files Patent Applications for Ovarian Cancer Screening Test Development

Cleo Diagnostics Ltd (ASX:COV) is an Australian medical technology company developing diagnostic solutions for ovarian cancer detection. The company’s shares were trading at AUD 0.30, up nearly 6% on 30 September 2026 at 1:16 pm. Cleo Diagnostics has announced the filing of two provisional …

Sonal Goyal | 30 September 2026
Support

Hi! How can we help you today?

Loading…